Stran & Company, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Earnings (Loss) Per Share

Earnings (Loss) Per Share

9 Months Ended

Sep. 30, 2024

Earnings (Loss) Per Share [Abstract]

EARNINGS (LOSS) PER SHARE:

The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods in which a net loss is presented because their effect would have been anti-dilutive.

	Three and Nine Months Ended September 30, 2024		Nine Months Ended September 30, 2023
			(Restated)
Warrants		10,074,195		10,074,195
Stock options		955,334		630,228
		11,029,529		10,704,423

For the three and nine months ended September 30, 2024, and for the nine months ended September 30, 2023, as a result of the net losses in these periods, all warrants and stock options have been excluded from the calculation of diluted earnings per share and, therefore, there was no difference in the weighted average number of common shares for basic and diluted loss per share as the effect of all potentially dilutive shares outstanding was anti-dilutive.

The following table presents the computation of basic and diluted earnings per share for the three months ended September 30, 2023:

	Three Months Ended September 30, 2023
	(Restated)
	Net income		Shares
Net income	$	1,265		18,534,772
Basic earnings per share			$	0.07

Effect of dilutive securities:
Warrants		—		10,074,195
Stock options		—		630,228
	$	1,265		29,239,195
Diluted earnings per share			$	0.04